VIVUS Inc (NASDAQ:VVUS)

0.8294
Delayed Data
As of Jun 18
 -0.0096 / -1.14%
Today’s Change
0.33
Today|||52-Week Range
1.32
+65.02%
Year-to-Date
Can The Uptrend Continue for VIVUS (VVUS)?
Jun 11 / Zacks.com - Paid Partner Content
3 Biotech Stocks Up in the Past Month on Industry Turnaround
Jun 05 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close0.84
Today’s open0.83
Day’s range0.80 - 0.83
Volume598,904
Average volume (3 months)1,196,840
Market cap$57.1M
Data as of 4:00pm ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)-231.82%
Earnings growth (this year)-48.28%
Earnings growth (next 5 years)+0.84%
Revenue growth (last year)-47.39%
P/E ratioNM
Price/Sales0.81
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GEMPGemphire Therapeutic...+0.03+0.41%
ALIMAlimera Sciences Inc+0.00+0.36%
MEIPMEI Pharma Inc+0.25+5.90%
ZFGNZafgen Inc+0.42+5.97%
Data as of 4:00pm ET, 06/18/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$65.4M
Annual profit (last year)-$30.5M
Net profit margin-46.67%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
John P. Amos
President &
Independent Director
Thomas Braxton King
Corporate headquarters
Campbell, California

Forecasts